The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.

Injection of botulinum toxin (Botox) into the laryngeal muscles has become the treatment of choice for controlling the symptoms of spasmodic dysphonia (SD). Currently, no specific battery of objective tests to assess the outcome is universally accepted. The purpose of this study was to investigate demographic, clinical, and treatment factors with voice outcome following Botox injection. Sixty-eight patients with adductor SD who underwent at least one Botox injection during a 5-year period were studied. Voice outcome measures were made from patient self-reporting scales and included overall vocal quality, length of response, and duration of breathiness. Vocal quality was significantly correlated with the underlying severity of vocal symptoms prior to treatment, incidence of breathiness and unilateral versus bilateral injection. The length of response was greater in males and following bilateral injections. An increased period of breathiness significantly correlated with bilateral injections.

[1]  J. Jankovic,et al.  Therapeutic uses of botulinum toxin. , 1991, The New England journal of medicine.

[2]  J. Jankovic,et al.  Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. , 1987, Archives of otolaryngology--head & neck surgery.

[3]  M Swenson,et al.  Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: Acoustic, aerodynamic, and videoendoscopic findings , 1992, The Laryngoscope.

[4]  C. Ludlow,et al.  Technique for Injection of Botulinum Toxin through the Flexible Nasolaryngoscope , 1994 .

[5]  M. Brin,et al.  Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia) , 1988, The Laryngoscope.

[6]  M. Hallett,et al.  Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia , 1988, Neurology.

[7]  W J Litchy,et al.  Botulinum toxin injection for adductor spastic dysphonia: Patient self‐ratings of voice and phonatory effort after three successive injections , 1993, The Laryngoscope.

[8]  A. Aronson,et al.  Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphonia , 1991, The Laryngoscope.

[9]  D. Bless,et al.  Indirect Laryngoscopic Approach for Injection of Botulinum Toxin in Spasmodic Dysphonia , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  T. Murry,et al.  Spasmodic dysphonia. Emotional status and botulinum toxin treatment. , 1994, Archives of otolaryngology--head & neck surgery.

[11]  D. R. Boone,et al.  Adductor Spastic Dysphonia: Heterogeneity of Physiologic and Phonatory Characteristics , 1988, The Annals of otology, rhinology, and laryngology.

[12]  M. Morrison,et al.  A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia. , 1994, The Journal of otolaryngology.

[13]  C. Ludlow,et al.  Comparison of Muscle Activation Patterns in Adductor and Abductor Spasmodic Dysphonia , 1994, The Annals of otology, rhinology, and laryngology.

[14]  J. Howard,et al.  Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia , 1994, The Laryngoscope.